Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...
University of California, San Francisco

Wearable Tech Can Help Heart Surgery Patients Stick with Rehab

Nurse scientist Linda Park, PhD, uses NIH funding to study cardiac rehab and digital tools—like pedometers and apps—to ...